Skip to main content

Table 1 Clinical parameters of MM patients

From: Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay

Patient Sex/age Clinical state Monoclonal Ig % PCs in BM
1 F/42 Onset IgG-k 52
2 M/71 Relapse IgG-L 29
3 M/52 Onset IgA-k 30
4 M/73 Smoldering IgG-L 22
5 F/73 Smoldering IgA-L 34
6 M/50 Onset IgG-L 60
7 F/68 Relapse IgG-L 19
8 M/75 Relapse Micro-k 90
9 M/58 Onset IgG-k 60
10 F/46 Onset IgG-L 67
11 M/75 Relapse IgG-k 32
12 M/71 Relapse IgG-k 52
13 F/78 Relapse IgG-k 51
14 M/68 Relapse IgG-k 44
15 M/75 Onset IgG-L 24
16 F/54 Onset IgG-L 34
17 F/61 Relapse IgG-L 38
18 F/78 Onset IgG-k 40
19 M/73 Smoldering IgG-λ 13
20 M/71 Onset IgG-k 60
  1. Patients were classified according to the status of disease. The percentage of plasma cells in the BM and monoclonal Ig is indicated